Active, not recruitingPHASE1, PHASE2NCT02315027

Mesenchymal Stem Cell Therapy in Multiple System Atrophy

Studying Multiple system atrophy

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Mayo Clinic
Principal Investigator
Wolfgang Singer, MD
Mayo Clinic
Intervention
Autologous Mesenchymal Stem Cells(biological)
Enrollment
30 target
Eligibility
30-80 years · All sexes
Timeline
2012 – 2026

Study locations (1)

Collaborators

Food and Drug Administration (FDA) · National Institute of Neurological Disorders and Stroke (NINDS)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02315027 on ClinicalTrials.gov

Other trials for Multiple system atrophy

Additional recruiting or active studies for the same condition.

See all trials for Multiple system atrophy →

← Back to all trials